Final  ||| S:0 E:6 ||| JJ
report  ||| S:6 E:13 ||| NN
on  ||| S:13 E:16 ||| IN
the  ||| S:16 E:20 ||| DT
safety  ||| S:20 E:27 ||| NN
assessment  ||| S:27 E:38 ||| NN
of  ||| S:38 E:41 ||| IN
PPG-2  ||| S:41 E:47 ||| CD
methyl  ||| S:47 E:54 ||| JJ
ether ||| S:54 E:59 ||| NN
,  ||| S:59 E:61 ||| ,
PPG-3  ||| S:61 E:67 ||| FW
methyl  ||| S:67 E:74 ||| FW
ether ||| S:74 E:79 ||| FW
,  ||| S:79 E:81 ||| ,
and  ||| S:81 E:85 ||| CC
PPG-2  ||| S:85 E:91 ||| FW
methyl  ||| S:91 E:98 ||| FW
ether  ||| S:98 E:104 ||| FW
acetate  ||| S:104 E:112 ||| FW
PPG-2  ||| S:112 E:118 ||| FW
methyl  ||| S:118 E:125 ||| FW
ether ||| S:125 E:130 ||| FW
,  ||| S:130 E:132 ||| ,
PPG-3  ||| S:132 E:138 ||| FW
methyl  ||| S:138 E:145 ||| FW
ether ||| S:145 E:150 ||| FW
,  ||| S:150 E:152 ||| ,
and  ||| S:152 E:156 ||| CC
PPG-2  ||| S:156 E:162 ||| CD
methyl  ||| S:162 E:169 ||| CD
ether  ||| S:169 E:175 ||| CD
acetate  ||| S:175 E:183 ||| NNS
are  ||| S:183 E:187 ||| VBP
used  ||| S:187 E:192 ||| VBN
in  ||| S:192 E:195 ||| IN
cosmetics  ||| S:195 E:205 ||| NNS
as  ||| S:205 E:208 ||| IN
fragrance  ||| S:208 E:218 ||| JJ
ingredients  ||| S:218 E:230 ||| NNS
and ||| S:230 E:233 ||| CC
/ ||| S:233 E:234 ||| NNP
or  ||| S:234 E:237 ||| CC
solvents  ||| S:237 E:246 ||| NNS
at  ||| S:246 E:249 ||| IN
concentrations  ||| S:249 E:264 ||| NNS
of  ||| S:264 E:267 ||| IN
0.4 ||| S:267 E:270 ||| CD
%  ||| S:270 E:272 ||| NN
to  ||| S:272 E:275 ||| TO
2 ||| S:275 E:276 ||| CD
% ||| S:276 E:277 ||| NN
.  ||| S:277 E:279 ||| .
Propylene  ||| S:279 E:289 ||| JJ
glycol  ||| S:289 E:296 ||| JJ
ethers  ||| S:296 E:303 ||| NNS
are  ||| S:303 E:307 ||| VBP
rapidly  ||| S:307 E:315 ||| RB
absorbed  ||| S:315 E:324 ||| VBN
and  ||| S:324 E:328 ||| CC
distributed  ||| S:328 E:340 ||| VBN
throughout  ||| S:340 E:351 ||| IN
the  ||| S:351 E:355 ||| DT
body  ||| S:355 E:360 ||| NN
when  ||| S:360 E:365 ||| WRB
introduced  ||| S:365 E:376 ||| VBN
by  ||| S:376 E:379 ||| IN
inhalation  ||| S:379 E:390 ||| NN
or  ||| S:390 E:393 ||| CC
oral  ||| S:393 E:398 ||| JJ
exposure ||| S:398 E:406 ||| NN
,  ||| S:406 E:408 ||| ,
but  ||| S:408 E:412 ||| CC
the  ||| S:412 E:416 ||| DT
inhalation  ||| S:416 E:427 ||| JJ
toxicity  ||| S:427 E:436 ||| NN
of  ||| S:436 E:439 ||| IN
PPG-2  ||| S:439 E:445 ||| FW
methyl  ||| S:445 E:452 ||| FW
ether  ||| S:452 E:458 ||| FW
vapor ||| S:458 E:463 ||| FW
,  ||| S:463 E:465 ||| ,
for  ||| S:465 E:469 ||| IN
example ||| S:469 E:476 ||| NN
,  ||| S:476 E:478 ||| ,
is  ||| S:478 E:481 ||| VBZ
low ||| S:481 E:484 ||| JJ
.  ||| S:484 E:486 ||| .
Aerosols ||| S:486 E:494 ||| NNP
,  ||| S:494 E:496 ||| ,
such  ||| S:496 E:501 ||| JJ
as  ||| S:501 E:504 ||| IN
found  ||| S:504 E:510 ||| VBN
with  ||| S:510 E:515 ||| IN
hair  ||| S:515 E:520 ||| NN
sprays ||| S:520 E:526 ||| NNS
,  ||| S:526 E:528 ||| ,
produce  ||| S:528 E:536 ||| VB
particle  ||| S:536 E:545 ||| JJ
sizes  ||| S:545 E:551 ||| NNS
that  ||| S:551 E:556 ||| WDT
are  ||| S:556 E:560 ||| VBP
not  ||| S:560 E:564 ||| RB
respirable ||| S:564 E:574 ||| VBN
.  ||| S:574 E:576 ||| .
Because  ||| S:576 E:584 ||| IN
these  ||| S:584 E:590 ||| DT
ingredients  ||| S:590 E:602 ||| NNS
are  ||| S:602 E:606 ||| VBP
highly  ||| S:606 E:613 ||| RB
water-soluble ||| S:613 E:626 ||| JJ
,  ||| S:626 E:628 ||| ,
they  ||| S:628 E:633 ||| PRP
are  ||| S:633 E:637 ||| VBP
likely  ||| S:637 E:644 ||| JJ
to  ||| S:644 E:647 ||| TO
be  ||| S:647 E:650 ||| VB
absorbed  ||| S:650 E:659 ||| VBN
through  ||| S:659 E:667 ||| IN
the  ||| S:667 E:671 ||| DT
human  ||| S:671 E:677 ||| JJ
skin  ||| S:677 E:682 ||| NN
only  ||| S:682 E:687 ||| RB
at  ||| S:687 E:690 ||| IN
slow  ||| S:690 E:695 ||| JJ
rates ||| S:695 E:700 ||| NNS
,  ||| S:700 E:702 ||| ,
resulting  ||| S:702 E:712 ||| VBG
in  ||| S:712 E:715 ||| IN
low  ||| S:715 E:719 ||| JJ
blood  ||| S:719 E:725 ||| NN
concentrations  ||| S:725 E:740 ||| NNS
and  ||| S:740 E:744 ||| CC
rapid  ||| S:744 E:750 ||| JJ
removal  ||| S:750 E:758 ||| NN
by  ||| S:758 E:761 ||| IN
the  ||| S:761 E:765 ||| DT
kidney ||| S:765 E:771 ||| NN
.  ||| S:771 E:773 ||| .
These  ||| S:773 E:779 ||| DT
ingredients  ||| S:779 E:791 ||| NNS
are  ||| S:791 E:795 ||| VBP
not  ||| S:795 E:799 ||| RB
genotoxic  ||| S:799 E:809 ||| JJ
and  ||| S:809 E:813 ||| CC
are  ||| S:813 E:817 ||| VBP
not  ||| S:817 E:821 ||| RB
reproductive  ||| S:821 E:834 ||| JJ
or  ||| S:834 E:837 ||| CC
developmental  ||| S:837 E:851 ||| JJ
toxicants ||| S:851 E:860 ||| NN
.  ||| S:860 E:862 ||| .
Overall  ||| S:862 E:870 ||| RB
the  ||| S:870 E:874 ||| DT
data  ||| S:874 E:879 ||| NNS
are  ||| S:879 E:883 ||| VBP
sufficient  ||| S:883 E:894 ||| JJ
to  ||| S:894 E:897 ||| TO
conclude  ||| S:897 E:906 ||| VB
that  ||| S:906 E:911 ||| IN
PPG-2  ||| S:911 E:917 ||| CD
methyl  ||| S:917 E:924 ||| JJ
ether ||| S:924 E:929 ||| NN
,  ||| S:929 E:931 ||| ,
PPG-3  ||| S:931 E:937 ||| FW
methyl  ||| S:937 E:944 ||| FW
ether ||| S:944 E:949 ||| FW
,  ||| S:949 E:951 ||| ,
and  ||| S:951 E:955 ||| CC
PPG-2  ||| S:955 E:961 ||| CD
methyl  ||| S:961 E:968 ||| CD
ether  ||| S:968 E:974 ||| CD
acetate  ||| S:974 E:982 ||| NNS
are  ||| S:982 E:986 ||| VBP
safe  ||| S:986 E:991 ||| JJ
as  ||| S:991 E:994 ||| IN
used  ||| S:994 E:999 ||| VBN
in  ||| S:999 E:1002 ||| IN
cosmetics ||| S:1002 E:1011 ||| NNS
.  ||| S:1011 E:1013 ||| .
